Skip to content

STI increase continues to slow in UK, but is still much cause for concern

Methadone included, tenofovir excluded, from new WHO essential drugs list

Pegylated interferon superior to lamivudine for first line hepatitis B treatment

Pfizer discontinues capravirine development

HAART and harvest: antiretroviral therapy and nutrition when food is scarce

3 million on treatment target unlikely to be met by end of 2005, says WHO

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Efavirenz reduces blood statin concentrations

Bristol Myers Squibb to cut price of two HIV drugs for children